North America dominates the Endoscopic Carpal Tunnel Release System market with a 40% share, driven by advanced healthcare infrastructure, high adoption of minimally invasive procedures, and robust reimbursement policies. The regionโs aging population and rising prevalence of repetitive strain injuries further accelerate demand. Europe follows with 30%, supported by stringent regulatory frameworks ensuring device safety, strong public healthcare systems, and growing awareness among clinicians. Asia Pacific emerges as the fastest-growing region, with 20% market share, fueled by expanding private healthcare investments, rising disposable incomes, and a large working population exposed to musculoskeletal disorders. Latin America and the Middle East & Africa collectively account for 10%, with incremental growth spurred by urbanization and improving surgical training programs, though infrastructure gaps and economic constraints temper expansion.